Loading...

Hangzhou Tigermed Consulting Co., Ltd.

HNGZYPNK
HealthcareMedical - Diagnostics & Research
$4.00
$0.00(0.00%)

Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) Company Profile & Overview

Explore Hangzhou Tigermed Consulting Co., Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) Company Profile & Overview

Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEODr. Xiaoping Ye D.Phil, EMBA, M.D., Ph.D.

Contact Information

86 57 1288 87227
F18, Building A – Shengda Science Park, Hangzhou, 310051

Company Facts

10,185 Employees
IPO DateJul 11, 2022
CountryCN

Frequently Asked Questions